Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.03% | 178.81 | 0.7% | $1159.32m | |
| LLY | Eli Lilly & Co. | -0.59% | 368.23 | 1.1% | $1130.48m | |
| MRK | Merck & Co., Inc. | -0.54% | 109.24 | 0.7% | $1027.68m | |
| PFE | Pfizer Inc. | -0.25% | 51.01 | 0.9% | $989.28m | |
| ABBV | AbbVie, Inc. | -0.03% | 161.58 | 1.9% | $866.05m | |
| BMY | Bristol-Myers Squibb Co. | 0.30% | 81.11 | 1.1% | $773.98m | |
| AZN | AstraZeneca Plc | 0.00% | 68.34 | 1.0% | $358.11m | |
| HZNP | Horizon Therapeutics Plc | 3.09% | 104.00 | 5.4% | $318.77m | |
| IDXX | IDEXX Laboratories, Inc. | 0.00% | 439.17 | 3.9% | $229.98m | |
| CTLT | Catalent, Inc. | 0.02% | 52.24 | 1.9% | $213.67m | |
| GSK | GSK Plc | 0.21% | 35.11 | 0.3% | $190.15m | |
| NVS | Novartis AG | -0.21% | 89.62 | 0.2% | $185.93m | |
| NVO | Novo Nordisk A/S | 0.00% | 126.13 | 0.1% | $172.82m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.00% | 220.25 | 8.0% | $161.43m | |
| RGEN | Repligen Corp. | 0.00% | 188.17 | 6.7% | $134.32m |
Company Profile
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.